Labcorp (LH) Form 144: Proposed sale of 7,009 shares on NYSE
LH filed a Form 144 notice for a proposed sale of 7,009 shares of common stock on the NYSE, with an approximate sale date of 10/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LH filed a Form 144 notice for a proposed sale of 7,009 shares of common stock on the NYSE, with an approximate sale date of 10/31/2025. The filing lists an aggregate market value of $1,782,273.05 for the proposed sale and names Fidelity Brokerage Services LLC as broker. Shares outstanding were 82,900,000.
The shares to be sold were acquired through restricted stock vesting from 2018 through 2025, including tranches such as 1,263 (02/07/2018), 1,227 (02/12/2020), 986 (02/04/2021), 947 (02/07/2024), and 944 (02/06/2025), summing to 7,009 shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.